相关实验视频
Updated: Jun 29, 2025
08:34
Isolation of Atrial Myocytes from Adult Mice
Published on: July 25, 2019
10.4K
B型天然尿素抑制了SERCA2a在心力衰竭中的表达和功能
Yuting Zhai1,2, Junhong Chen3, Rongsheng Kan1
1Institute of Cardiovascular Disease Research, Xuzhou Medical University.
International heart journal
|March 31, 2024
概括
B型尿素 (BNP) 抑制了细胞/内细胞网膜ATPase 2a (SERCA2a) 的表达和功能. 这种相互作用对于涉及BNP或SERCA2a基因疗法的心力衰竭 (HF) 治疗考虑至关重要.
科学领域:
- 心血管生物学 心血管生物学
- 分子心脏病学分子心脏病学
- 生物化学 生化学
背景情况:
- B型尿素 (BNP) 已知具有心血管保护作用,但潜在的副作用需要进一步调查.
- ATPase 2a (SERCA2a) 是心力衰竭 (HF) 治疗的有前途的目标,但基因疗法试验没有成功.
- 升高的BNP水平和降低的SERCA2a表达是HF的特征,并显示出负相关性.
研究的目的:
- 调查BNP抑制SERCA2a表达和功能的假设.
- 在心力衰竭模型中确定BNP对内源和外源SERCA2a表达和功能的影响.
主要方法:
- 在体内研究中,使用小鼠进行了由横向大动脉收缩引起的HF.
- 使用新生小鼠心肌细胞 (NRCM) 的体外研究.
- 在两种模型中对BNP和腺病毒介导的SERCA2a过度表达的干预.
主要成果:
- 在体内,增加的BNP水平与HF和BNP治疗小鼠的SERCA2a表达减少相关.
- 服用BNP可以降低心肌中内源性和外源性SERCA2a蛋白水平.
- 在体外,BNP剂量依赖地通过激活cGMP依赖蛋白激酶G来抑制NRCM中的SERCA2a表达和功能.
- 布朗尼基抗击了SERCA2a过度表达对心肌细胞处理的有益影响.
结论:
- 尼巴尼抑制了内源性和外源性SERCA2a的表达和功能.
- 在心力衰竭的治疗策略中,BNP和SERCA2a之间的反向关系需要仔细考虑.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
424
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
424
01:22Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
01:27Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
01:22Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
81
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
81
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
720
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
720